AstraZeneca may have used outdated info in its coronavirus vaccine trial
Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information,” federal health officials said early Tuesday.
The Data and Safety Monitoring Board said in a statement that it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data of the two-dose vaccine.
Image by Hans Braxmeier from Pixabay
** This post was originally published on March 23, 2021 **